Active ingredientFosamprenavirCat. No. P-F116-001CAS 226700-79-4Family · Pharmaceutical analytical standards
Fosamprenavir
An HIV protease inhibitor, a prodrug of amprenavir approved in the United States in 2003: in the body it is converted into the active drug, which prevents new virus particles from maturing. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?The added phosphate group makes it far more soluble in water: as a result, amprenavir's eight capsules per dose shrink to one or two tablets.
Go to the active ingredient →Active ingredientFosamprenavirCat. No. P-F116-001CAS 226700-79-4
Active ingredientFosamprenavir CalciumCat. No. P-F116-002CAS 226700-81-8
Isotopically labelledFosamprenavir-d4Cat. No. P-F116-003CAS 1133702-41-6
Isotopically labelledFosamprenavir-d4 Calcium saltCat. No. P-F116-004![2(S)-[1(S)-azido-2-phenylethyl]oxirane](https://img.vitasanlabs.com/vsl-struct/P-F116-006.svg?v=41e934f030)
Impurity2(S)-[1(S)-azido-2-phenylethyl]oxiraneCat. No. P-F116-006CAS 136465-89-9
ImpurityFosamprenavir Impurity 1Cat. No. P-F116-007CAS 128018-43-9
ImpurityFosamprenavir enantiomerCat. No. P-F116-008
ImpurityFosamprenavir Impurity 2Cat. No. P-F116-009CAS 160333-50-6
ImpurityFosamprenavir Impurity 3Cat. No. P-F116-010
ImpurityFosamprenavir Impurity 4Cat. No. P-F116-011CAS 853904-81-1
ImpurityFosamprenavir Impurity 5Cat. No. P-F116-012CAS 1005324-40-2
ImpurityFosamprenavir Impurity 6Cat. No. P-F116-013CAS 143225-31-4
ImpurityFosamprenavir Impurity 7Cat. No. P-F116-015
ImpurityFosamprenavir Impurity 8Cat. No. P-F116-016CAS 316123-26-9
ImpurityFosamprenavir Impurity 9Cat. No. P-F116-017
ImpurityFosamprenavir PyrophosphateCat. No. P-F116-018CAS 316123-24-7
ImpurityFosamprenavir Impurity 10Cat. No. P-F116-019CAS 2078048-42-5
ImpurityFosamprenavir Related Compound ACat. No. P-F116-020No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.